We are live on ! Find out more
SANA icon

Sana Biotechnology
SANA

161 hedge funds and large institutions have $252M invested in Sana Biotechnology in 2025 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 54 increasing their positions, 41 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more call options, than puts

Call options by funds: $1.06M | Put options by funds: $712K

32% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 41

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

3% less capital invested

Capital invested by funds: $258M → $252M (-$6.75M)

9% less first-time investments, than exits

New positions opened: 29 | Existing positions closed: 32

2% less funds holding

Funds holding: 164 → 161 (-3)

4.44% less ownership

Funds ownership: 70.78% → 66.34% (-4.4%)

Holders
161
Holders Change
-3
Holders Change %
-1.83%
% of All Funds
2.16%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
29
Increased
54
Reduced
41
Closed
32
Calls
$1.06M
Puts
$712K
Net Calls
+$353K
Net Calls Change
-$1.61M

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$6.14M
2
CC
Clearline Capital
New York
+$1.15M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$990K
4
Deutsche Bank
Deutsche Bank
Germany
+$871K
5
UBS Group
UBS Group
Switzerland
+$783K

Top Sellers

1
Vanguard Group
Vanguard Group
Pennsylvania
-$8.06M
2
State Street
State Street
Massachusetts
-$3.4M
3
Morgan Stanley
Morgan Stanley
New York
-$3.03M
4
BCM
Boxer Capital Management
California
-$2.52M
5
Corient Private Wealth
Corient Private Wealth
Florida
-$2.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
176
LMR Partners
United Kingdom
– -$73.9K -45,356 Closed
OF
177
Optimize Financial
California
– -$69.9K -42,878 Closed
VEA
178
Virtus ETF Advisers
New York
– -$56.8K -34,849 Closed
EGM
179
Engineers Gate Manager
New York
– -$46.2K -28,352 Closed
PD
180
Point72 (DIFC)
United Arab Emirates
– -$37.4K -22,926 Closed
LPL Financial
181
LPL Financial
California
– -$21.4K -13,140 Closed
RL
182
RPO LLC
Connecticut
– -$20.9K -12,803 Closed
Principal Financial Group
183
Principal Financial Group
Iowa
– -$20.4K -12,499 Closed
VCM
184
Voleon Capital Management
California
– -$19.7K -12,098 Closed
PAS
185
Point72 Asia (Singapore)
Singapore
– -$18.9K -11,571 Closed
Stifel Financial
186
Stifel Financial
Missouri
– -$16.9K -10,397 Closed
RS
187
R Squared
Hong Kong
– -$4.24K -2,600 Closed
CIAM
188
Caitong International Asset Management
Hong Kong
– -$1.37K -843 Closed
IA
189
IFP Advisors
Florida
– -$15 -9 Closed
Federated Hermes
190
Federated Hermes
Pennsylvania
– -$8 -5 Closed
C
191
Covestor
United Kingdom
– +$3 +1 +4%
Bessemer Group
192
Bessemer Group
New Jersey
– +$249 +89 New
4 5 6 7
8

SANA Hedge Fund Activity: Q1 2025 in Review

161 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Sana Biotechnology (SANA) for Q1 2025, worth a combined $252M — down 2.6% from $258M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of SANA and 29 opened new positions — a net loss of 3 holders — while 41 trimmed existing stakes and 54 added.

The largest buyer was Citadel Advisors, adding an estimated $6.14M. The largest seller was Vanguard Group, cutting an estimated $8.06M.

  • 161 institutional investors held Sana Biotechnology (SANA) as of Q1 2025, down from 164 in Q4 2024.
  • Funds reported $252M of Sana Biotechnology stock for Q1 2025, down 2.6% quarter-over-quarter.
  • 29 funds opened new Sana Biotechnology positions in Q1 2025 and 32 closed out, a net change of -3 holders.
  • The largest Sana Biotechnology buyer in Q1 2025 was Citadel Advisors, an estimated $6.14M added.
  • The largest Sana Biotechnology seller in Q1 2025 was Vanguard Group, an estimated $8.06M sold.

Based on aggregated 13F filings for Q1 2025.